63 100

Cited 4 times in

Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial

Authors
 Kyeongman Jeon  ;  Jae Kyung Suh  ;  Eun Jin Jang  ;  Songhee Cho  ;  Ho Geol Ryu  ;  Sungwon Na  ;  Sang-Bum Hong  ;  Hyun Joo Lee  ;  Jae Yeol Kim  ;  Sang-Min Lee 
Citation
 JOURNAL OF KOREAN MEDICAL SCIENCE, Vol.34(14) : e110, 2019 
Journal Title
 JOURNAL OF KOREAN MEDICAL SCIENCE 
ISSN
 1011-8934 
Issue Date
2019
MeSH
Aged ; Anti-Bacterial Agents/economics ; Anti-Bacterial Agents/therapeutic use* ; Biomarkers/analysis ; Cost of Illness ; Critical Illness ; Female ; Hospital Mortality ; Humans ; Intensive Care Units ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Procalcitonin/analysis* ; Sepsis/drug therapy* ; Sepsis/mortality ; Sepsis/pathology ; Single-Blind Method
Keywords
Anti-Bacterial Agents ; Biomarkers ; Calcitonin ; Economics ; Intensive Care Unit ; Sepsis
Abstract
BACKGROUND: The objective of this study was to establish the efficacy and safety of procalcitonin (PCT)-guided antibiotic discontinuation in critically ill patients with sepsis in a country with a high prevalence of antimicrobial resistance and a national health insurance system. METHODS: In a multi-center randomized controlled trial, patients were randomly assigned to a PCT group (stopping antibiotics based on a predefined cut-off range of PCT) or a control group. The primary end-point was antibiotic duration. We also performed a cost-minimization analysis of PCT-guided antibiotic discontinuation. RESULTS: The two groups (23 in the PCT group and 29 in the control group) had similar demographic and clinical characteristics except for need for renal replacement therapy on ICU admission (46% vs. 14%; P = 0.010). In the per-protocol analysis, the median duration of antibiotic treatment for sepsis was 4 days shorter in the PCT group than the control group (8 days; interquartile range [IQR], 6-10 days vs. 14 days; IQR, 12-21 days; P = 0.001). However, main secondary outcomes, such as clinical cure, 28-day mortality, hospital mortality, and ICU and hospital stays were not different between the two groups. In cost evaluation, PCT-guided therapy decreased antibiotic costs by USD 30 (USD 241 in the PCT group vs. USD 270 in the control group). The results of the intention-to-treat analysis were similar to those obtained for the per-protocol analysis. CONCLUSION: PCT-guided antibiotic discontinuation in critically ill patients with sepsis could reduce the duration of antibiotic use and its costs with no apparent adverse outcomes.
Files in This Item:
T201904509.pdf Download
DOI
10.3346/jkms.2019.34.e110
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) > 1. Journal Papers
Yonsei Authors
Na, Sungwon(나성원) ORCID logo https://orcid.org/0000-0002-1170-8042
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/173335
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links